$1.03
0.00%
Nasdaq, Wed, Sep 16 2026.
ISIN
US63008J1088
Symbol
NAOV

NanoVibronix, Inc. Stock price

$1.03
-4.54 81.51% 1M
-20.93 95.31% 6M
-26.69 96.28% YTD
-90.77 98.88% 1Y
-3,549.77 99.97% 3Y
-55,438.97 100.00% 5Y
-145,198.97 100.00% 10Y
-92,398.97 100.00% 20Y
Nasdaq, Closing price Wed, Sep 16 2026
+0.00 0.00%

Is NanoVibronix, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,134 stocks worldwide.

Key metrics

Basic
Market capitalization
-
Enterprise Value
-
Net debt
-
Cash
-
Shares outstanding
-
Valuation (TTM | estimate)
P/E
negative
P/S
- | -
EV/Sales
- | -
EV/FCF
-
P/B
-
Financial Health
Equity Ratio
17.3%
Return on Equity
-590.9%
ROCE
-21.0%
ROIC
-22.3%
Debt/Equity
-
Financials (TTM | estimate)
Revenue
$2.7m | -
EBITDA
$-8.8m
EBIT
$-9.4m
Net Income
$-5.2m
Free Cash Flow
$-7.3m
Growth (TTM | estimate)
Revenue
-18.2% | -
EBITDA
-202.7%
EBIT
-224.1%
Net Income
-68.6%
Free Cash Flow
-195.9%
Margin
Gross
30.0%
EBITDA
-328.0%
EBIT
-351.8%
Net
-193.9%
Free Cash Flow
-271.2%
More
EPS
$-6.1
FCF per Share
$-9.2
Short interest
2.1%
Employees
31
Rev per Employee
$80.0k

NanoVibronix, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a NanoVibronix, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a NanoVibronix, Inc. forecast:

Buy
86%
Hold
14%

Financial data from NanoVibronix, Inc.

Sep '25
+/-
%
2.69 2.69
18% 18%
100%
- Direct Costs 1.88 1.88
41% 41%
70%
0.81 0.81
59% 59%
30%
- Selling and Administrative Expenses 8.18 8.18
92% 92%
304%
- Research and Development Expense 2.08 2.08
235% 235%
77%
-8.81 -8.81
203% 203%
-328%
- Depreciation and Amortization 0.64 0.64
-
24%
EBIT (Operating Income) EBIT -9.45 -9.45
224% 224%
-351%
Net Profit -5.21 -5.21
69% 69%
-194%

In millions USD.

Don't miss a Thing! We will send you all news about NanoVibronix, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. It targets wound healing and pain therapy, and can be administered at home, without the assistance of medical professionals. Its products include WoundShield, PainShield, and UroShield. It operates through the following geographical segments: United States, Israel, United Kingdom, European Union, India, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Melville, NY.

Head office United States
CEO Dr. Besser
Employees 31
Founded 2003
Website nanovibronix.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today